Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.5.1799

Predictive Value of Excision Repair Cross-complementing Rodent Repair Deficiency Complementation Group 1 and Ovarian Cancer Risk  

He, Shan-Yang (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University)
Xu, Lin (Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University)
Niu, Gang (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University)
Ke, Pei-Qi (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University)
Feng, Miao-Miao (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University)
Shen, Hong-Wei (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.5, 2012 , pp. 1799-1802 More about this Journal
Abstract
Objective: We aimed to analyze the association between excision repair cross-complementing rodent repair deficiency complementation group 1 (XRCC1) and ovarian cancer risk. Methods: We performed a hospital-based case-control study with 155 cases and 313 controls in China. All Chinese cases with newly diagnosed primary ovarian cancer between May 2005 to May 2010 in our hospital were invited to participate within 2 months of diagnosis. Controls were randomly selected from people who requested general health examinations in the same hospital during the same period. SNPs in EXCC1, ERCC1 C8092A and ERCC1 T19007C, were analyzed by PCR-RFLP method. Results: We observed a non-significantly increased risk of ovarian cancer among individuals with ERCC1 8092TT compared with those with the 8092CC genotype (adjusted OR=1.55, 95% CI%=0.74-2.97). Moreover, 19007TT genotype carriers also showed a non-significant increased risk of ovarian cancer over those with the 19007CC genotype (adjusted OR=1.78, 95% CI%=0.91-3.64). Conclusion: Our firstly investigation of links between polymorphisms in the ERCC1 gene and the risk of ovarian cancer in Chinese population demonstrated no significant association. Further large sample studies in Chinese populations are needed.
Keywords
Ovarian cancer; ERCC1; polymorphism; Chinese population;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Avraam K, Pavlakis K, Papadimitriou C, et al (2011). The prognostic and predictive value of ERCC-1, p53, bcl-2 and bax in epithelial ovarian cancer. Eur J Gynaecol Oncol, 32, 516-20.
2 Bessho T, Sancar A, Thompson LH, et al (1997). Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J Biol Chem, 272, 3833-7.   DOI
3 Jin F, Shu XO, Devesa SS, et al (1993). Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89. Cancer Causes Control, 4, 355-60.   DOI
4 Krivak TC, Darcy KM, Tian C, et al (2008). Gynecologic Oncology Group Phase III Trial.Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer. J Clin Oncol, 26, 3598-606.   DOI
5 Lin F, Lin K, Xie X, et al (2010). Increased ERCC1 protein expression is associated with suboptimal debulking in advanced epithelial ovarian cancer. Anticancer Res, 30, 2447-52.
6 Li QQ, Yunmbam MK, Zhong X, et al (2001). Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression. Cell Mol Biol (Noisy-le-grand), 47, OL61-72.
7 Liu Y, Scheurer ME, El-Zein R, et al (2009). Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev, 18, 204-14.   DOI
8 Matullo G, Guarrera S, Sacerdote C, et al (2005). Polymorphisms/ haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev, 14, 2569-78.   DOI
9 Moreno V, Gemignani F, Landi S, et al (2006). Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res, 12, 2101-8.   DOI   ScienceOn
10 Rajaraman P, Hutchinson A, Wichner S, et al (2010). DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol, 12, 37-48.   DOI
11 Reed E, Yu JJ, Davies A, et al (2003). Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer. Clin Cancer Res, 9, 5299-305.
12 Ries LAG, Young JL, Keel GE, et al (2007). SEER Program, NIH Pub. No. 07-6215. National Cancer Institute; Bethesda, MD: 2007. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics.
13 van Duin M, de Wit J, Odijk H, et al (1986). Molecular characterization of the human excision repair gene ERCC- 1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell, 44, 913-23.   DOI
14 Weberpals J, Garbuio K, O'Brien A, et al (2009). The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer. Int J Cancer, 124, 806-15.   DOI
15 Wilson MD, Ruttan CC, Koop BF, et al (2001). ERCC1: a comparative genomic perspective. Environ Mol Mutagen, 38, 209-15.   DOI
16 Zhou W, Liu G, Park S, et al (2005). Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev, 14, 491-6.   DOI
17 Zienolddiny S, Campa D, Lind H, et al (2006). Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 27, 560-7.   DOI   ScienceOn